News
|
|
Profits from hidden product reserves
Pharmaceutical products – and in particular biotech products – are getting more and more expensive. With prices of US$1,000 to 2,000 per disposable syringe, it is imperative to utilize even the smallest amount of the drug. Inova has now declared war on the “hidden product reserves” of the filling process. The introduction of the first line with new in-process control with special start-up and clear-out modes paid for itself in only three weeks.
 more
|
 |
|
|
New Cooperation for the OPTIMA GROUP Pharma
Today’s keyword is cooperation. Since line concepts play an increasingly important role in the pharmaceutical industry, the Optima Group Pharma has established a cooperation in the field of blister packaging. The specialists of Inova pharma systems GmbH and Uhlmann Pac Systeme GmbH & Co. KG are well recognized for their unique industry knowledge, which is reflected in the packaging solutions.
more
|
|
|
|
Improved cost and purchase perspective
Life Cycle Costing (LCC)The German Engineering Federation VDMA is currently working out a new cost calculation model, which for the first time offers the possibility of a comprehensive cost approach over the life cycle of capital goods. This model is supposed to serve as a tool for various industries, in order to make expenses, such as those associated with packaging machines outside of the purchase costs, predictable and ascertainable. This will also help to find the answer to the often-debated question of whether machines that are expensive in purchase price aren’t cheaper in the long run?
The German Engineering Federation VDMA is currently working out a new cost calculation model, which for the first time offers the possibility of a comprehensive cost approach over the life cycle of capital goods. This model is supposed to serve as a tool for various industries, in order to make expenses, such as those associated with packaging machines outside of the purchase costs, predictable and ascertainable. This will also help to find the answer to the often-debated question of whether machines that are expensive in purchase price aren’t cheaper in the long run?
more
|
|
|
|
New Product Line for the U.S.
Expanding Horizons
more
|
|
|
|
OPTIMA GROUP to the power of three
More transparency for customers with a new structure– this could be the overall ‘motto’ of the group’s new organizational set-up with its recently established divisions. As before, the group is operating in the fields of pharmaceuticals, consumer goods and nonwovens, however, now it is obvious at first sight. The company’s decision to focus on these target industries sets the pattern for the future.
more
|
|
|
|
OPTIMA GROUP Pharma Division management appointed
Jürgen Rothbauer and Jürgen P. Schäfer have taken over the management of the newly formed Optima Pharma Division. Mr. Rothbauer will remain CEO of Inova pharma systems GmbH, which together with Kugler, Klee and Autocon constitute the Optima Pharma Division. A graduate engineer aged 47, he has been working in the Optima group for 22 years and is primarily responsible for the technical direction. Jürgen P. Schäfer transfers from the Nonwovens Division management to the Pharma Division management, where he will be primarily concerned with sales. Having been with the company for 18 years, the 56 year old graduate industrial engineer has a wealth of experience in customer consulting, service and acquisition.
more
|
|
|
